Our Product Pipeline

Our products

Bold Health aims to tackle numerous digestive conditions through digital therapeutic products

At Bold, we develop new technologies based on evidence-based research with the potential to improve patient wellbeing. We then conduct extensive clinical studies, including prospective randomized controlled trials, to evaluate our products so they can be confidently prescribed by doctors and used by patients.

zemedy-flat-iconOur IBS app Zemedy is now live. Click here to find out more

Phase

Product

Therapeutic Area

DiscoveryPilotClinicalCE ApprovedFDA ApprovedAcademic Partner
section image
Irritable Bowel Syndrome (IBS)
check
section image
section image

BH/ 02

Inflammatory Bowel Disease (IBD)

BH/ 03

Gastroesophageal Reflux Disease (GERD)

BH/ 04

Eating Disorders

BH/ 05

Functional Dyspepsia

Scroll Along

Interested in our products?

If you’d like to learn more about any of our clinical trials underway, or you would like to explore a potential clinical trial collaboration please contact us. We’d love to hear from you.

section image